Research Output per year
Research Output per year
Fingerprint
Dive into the research topics where Robert J Chilton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 22 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
-
A focused review of cardiovascular guideline related recommendations for the primary care physician in the USA
Sheikh, O., Nashawi, M., Battisha, A. & Chilton, R., 2020, In: Cardiovascular Endocrinology and Metabolism. 9, 2, p. 36-41 6 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
A new perspective on lowering CV risk from hypoglycaemia
Solis-Herrera, C., Sheikh, O. & Chilton, R., Jan 1 2020, In: European Heart Journal. 41, 2, p. 218-220 3 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction
Nashawi, M., Sheikh, O., Battisha, A., Mir, M. & Chilton, R., 2020, (Accepted/In press) In: Heart Failure Reviews.Research output: Contribution to journal › Review article › peer-review
-
Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes
Chilton, R. J., Dungan, K. M., Shubrook, J. H. & Umpierrez, G. E., Jun 2020, In: Primary Care Diabetes. 14, 3, p. 193-212 20 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Pcsk9 inhibitors: From nature’s lessons to clinical utility
Raal, F. J., Chilton, R., Ranjith, N., Rambiritch, V., Leisegang, R. F., Ebrahim, I. O., van Tonder, A., Shunmoogam, N., Bouharati, C., Musa, M. G., Karamchand, S., Naidoo, P. & Blom, D. J., 2020, In: Endocrine, Metabolic and Immune Disorders - Drug Targets. 20, 6, p. 840-854 15 p.Research output: Contribution to journal › Review article › peer-review
Press / Media
-
SGLT2 inhibitors may have great potential in reducing HF in diabetes
7/23/19 → 7/24/19
2 items of Media coverage
Press/Media: Press / Media
-
Cardiologists Must 'Get Up To Speed' on Treating Diabetes
6/19/19 → 6/20/19
2 items of Media coverage
Press/Media: Press / Media
-
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy; SMART CRT
10/2/18
1 item of Media coverage
Press/Media: Press / Media
-
Orexigen Therapeutics Announces Multiple Contrave Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
9/30/17
1 item of Media coverage
Press/Media: Press / Media